Skip to main content
. 2008 Jun 21;14(23):3672–3680. doi: 10.3748/wjg.14.3672

Figure 3.

Figure 3

Ellagic acid induces loss of mitochondrial membrane potential, cytochrome C release, and caspase-3 activation in pancreatic cancer cells. MIA PaCa-2 (A-C) and PANC-1 (B) cells were cultured for 48 h in the presence or absence of indicated doses of ellagic acid or broad-spectrum caspase inhibitor zVAD-fmk (100 μmol/L). A: Changes in ΔΨm were measured by flow cytometry using the potential-sensitive probe 3,3’dihexyloxa-carbocyanine DiOC6 (3); B: Cytochrome C release was assessed by measuring cytochrome C levels in both cytosolic and mitochondria-enriched membrane fractions using Western blot analysis. Blots were re-probed for cytochrome C oxidase (COX IV), a specific mitochondrial marker. Western blots of cytosolic fractions re-probed for actin to confirm equal protein loading; C and D: Caspase-3 activity was assessed by measuring the DEVDase (caspase-3 like) activities in cell lysates using a fluorometric assay with a specific substrate. The results are representative of at least 3 independent experiments. Values are normalized to control (C and D). Values are mean ± SE (n = 3), aP < 0.05 vs control.